JPRN-UMIN000022720
Completed
未知
The measurement of the biomarker for diagnosis of th retinopathy of prematurity - The biomaker of ROP
Tokyo Metropolitan children's Medical Center0 sites100 target enrollmentJune 15, 2016
ConditionsRetinopathy of prematurity
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Retinopathy of prematurity
- Sponsor
- Tokyo Metropolitan children's Medical Center
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.neonate with chromosomal anomaly 2\.neonate with multiple malformation 3\.neonate with ophthalmogic abnormality 4\.neonate who is judged to be inappropriate as sublect.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
An exploratory investigation of the biomarker for senescence and arteriosclerosis in renal transplant donors and recipients.Recipients and donors in living-kidney transplantationJPRN-UMIN000004905Kagawa University, Faculty of Medicine45
Recruiting
Not Applicable
Identification and analysis of biomarkers for the course of demyelinating and inflammatory diseases of the central nervous system, in particular multiple sclerosisDemyelinating and inflammatory diseases of the central nervous system, in particular multiple sclerosisDRKS00031139MPI-NAT1,000
Recruiting
Not Applicable
An observational study to determine biomarkers for prognosis of lung lesions in patients with polymyositis/dermatomyositis complicated by interstitial lung diseasePolymyositis/dermatomyositis complicated with interstitial lung disease (PM/DM-ILD)JPRN-UMIN000046198agasaki University125
Recruiting
Not Applicable
A biomarker assessment study to investigate the influence of high-frequency chest wall oscillations on the clearance of cerebrospinal fluid biomarkersNL-OMON51372Centre for Human Drug Research34
Completed
Not Applicable
A study of cell signalling biomarkers in patients with tuberous sclerosisISRCTN62388748Aeovian Pharmaceuticals Inc.14